Jun Feng1, Kelsey Anderson1, Arun K Singh1, Afshin Ehsan1, Hunter Mitchell1, Yuhong Liu1, Frank W Sellke2. 1. Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, Rhode Island. 2. Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, Rhode Island. Electronic address: fsellke@lifesapn.org.
Abstract
BACKGROUND: We hypothesized that upregulation of inducible cyclooxygenase 2 (COX-2) contributes to altered coronary arteriolar reactivity early after cardioplegic arrest and cardiopulmonary bypass (CP/CPB) in patients with diabetes mellitus who are undergoing cardiac surgery. METHODS: The right atrial tissue samples of nondiabetes (ND), controlled diabetes (CDM), and uncontrolled diabetes (UDM) patients undergoing cardiac surgery were harvested before and after CP/CPB. Coronary arterioles (80 to 150 μm) were dissected from the harvested atrial tissue samples, cannulated, and pressurized. The changes in diameter were measured with video microscopy. The protein expression and localization of COX-1 and COX-2 were assayed by Western blot and immunohistochemistry. RESULTS: In the diabetes arterioles, bradykinin-induced relaxation response was inhibited by the selective COX-2 inhibitor NS398 at baseline (p < 0.05). This effect was more pronounced in UDM arterioles than CDM (p < 0.05). After CP/CPB, bradykinin-induced responses in all groups were inhibited by NS398, but this effect was more pronounced in the UDM patients (p < 0.05). The intensities of COX-2 staining of coronary arterioles and COX-2 protein levels in myocardium were higher in diabetes than nondiabetes at baseline (p < 0.05). The post-CP/CPB protein levels of the inducible COX-2 were significantly increased compared with pre-CP/CPB values in all groups (p < 0.05), whereas this increase was higher with diabetes than with ND (p < 0.05). Furthermore, these effects were more profound in UDM than CDM (p < 0.05). CONCLUSIONS: Diabetes and CP/CPB are associated with upregulation in COX-2 expression in human coronary vasculature. Upregulation of COX-2 expression may contribute to bradykinin-induced coronary arteriolar relaxation in diabetic patients undergoing cardiac surgery.
BACKGROUND: We hypothesized that upregulation of inducible cyclooxygenase 2 (COX-2) contributes to altered coronary arteriolar reactivity early after cardioplegic arrest and cardiopulmonary bypass (CP/CPB) in patients with diabetes mellitus who are undergoing cardiac surgery. METHODS: The right atrial tissue samples of nondiabetes (ND), controlled diabetes (CDM), and uncontrolled diabetes (UDM) patients undergoing cardiac surgery were harvested before and after CP/CPB. Coronary arterioles (80 to 150 μm) were dissected from the harvested atrial tissue samples, cannulated, and pressurized. The changes in diameter were measured with video microscopy. The protein expression and localization of COX-1 and COX-2 were assayed by Western blot and immunohistochemistry. RESULTS: In the diabetes arterioles, bradykinin-induced relaxation response was inhibited by the selective COX-2 inhibitor NS398 at baseline (p < 0.05). This effect was more pronounced in UDM arterioles than CDM (p < 0.05). After CP/CPB, bradykinin-induced responses in all groups were inhibited by NS398, but this effect was more pronounced in the UDMpatients (p < 0.05). The intensities of COX-2 staining of coronary arterioles and COX-2 protein levels in myocardium were higher in diabetes than nondiabetes at baseline (p < 0.05). The post-CP/CPB protein levels of the inducible COX-2 were significantly increased compared with pre-CP/CPB values in all groups (p < 0.05), whereas this increase was higher with diabetes than with ND (p < 0.05). Furthermore, these effects were more profound in UDM than CDM (p < 0.05). CONCLUSIONS:Diabetes and CP/CPB are associated with upregulation in COX-2 expression in human coronary vasculature. Upregulation of COX-2 expression may contribute to bradykinin-induced coronary arteriolar relaxation in diabeticpatients undergoing cardiac surgery.
Authors: Jun Feng; Yuhong Liu; Kamal R Khabbaz; Robert Hagberg; Michael P Robich; Richard T Clements; Cesario Bianchi; Frank W Sellke Journal: Surgery Date: 2010-08-21 Impact factor: 3.982
Authors: Tamás Szerafin; Nóra Erdei; Tibor Fülöp; Eniko T Pasztor; István Edes; Akos Koller; Zsolt Bagi Journal: Circ Res Date: 2006-08-17 Impact factor: 17.367
Authors: V H Thourani; W S Weintraub; B Stein; S S Gebhart; J M Craver; E L Jones; R A Guyton Journal: Ann Thorac Surg Date: 1999-04 Impact factor: 4.330
Authors: Jun Feng; Yuhong Liu; Kamal R Khabbaz; Robert Hagberg; Neel R Sodha; Robert M Osipov; Frank W Sellke Journal: Surgery Date: 2010-01-15 Impact factor: 3.982
Authors: Katrin Schröder; Min Zhang; Sebastian Benkhoff; Anja Mieth; Rainer Pliquett; Judith Kosowski; Christoph Kruse; Peter Luedike; U Ruth Michaelis; Norbert Weissmann; Stefanie Dimmeler; Ajay M Shah; Ralf P Brandes Journal: Circ Res Date: 2012-03-27 Impact factor: 17.367
Authors: Nicholas Sellke; Alex Kuczmarski; Isabella Lawandy; Victoria L Cole; Afshin Ehsan; Arun K Singh; Yuhong Liu; Frank W Sellke; Jun Feng Journal: J Thorac Cardiovasc Surg Date: 2018-06-08 Impact factor: 5.209
Authors: Nicholas Sellke; Caroline Gordon; Isabella Lawandy; Anastassia Y Gorvitovskaia; Laura A Scrimgeour; James G Fingleton; Frank W Sellke; Jun Feng Journal: J Surg Res Date: 2018-05-22 Impact factor: 2.192
Authors: Zhiqi Zhang; Guangbin Shi; Yuhong Liu; Hang Xing; Anatoli Y Kabakov; Amy S Zhao; Vahid Agbortoko; Justin Kim; Arun K Singh; Gideon Koren; Elizabeth O Harrington; Frank W Sellke; Jun Feng Journal: J Thorac Cardiovasc Surg Date: 2020-02-19 Impact factor: 5.209